Role of 18F-FDG PET/CT in the Evaluation of Cavernous Sinus Syndrome: a Pilot Study

Post Graduate Institute of Medical Education and Research, Chandigarh

Status: Completed

Conditions: Cavernous Sinus Lesions; Cavernous Sinus Syndrome; Cavernous Sinus Meningioma

Treatments: Diagnostic Test: FDG radiotracer

Study type: Observational

Funder types: Other

Identifiers

NCT06721130

1134

Details and patient eligibility

About

Cavernous sinus syndrome (CSS) can be caused by a wide range of inflammatory, malignant, benign, vascular and miscellaneous disorders. Even after modern advances, reaching the final etiological diagnosis remains a challenge in CSS. This study is planned to determine the role and incremental value of 18F-FDG PET/CT in characterising different cavernous sinus pathologies based on their metabolic activity and detecting extracranial involvement.

Enrollment: 54 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Patients with age greater than or equal to 18 years,
2. with newly diagnosed CSS,
3. lesion seen on MRI in the CS, and
4. willing to give written informed consent.

Exclusion criteria

1. Pregnant and lactating patients
2. Patients already being treated (including steroids)

Trial design

54 participants in 1 patient group

Treatment naive patients presenting with Cavernous Sinus Syndrome with cavernous sinus lesion on MRI

Treatment:

Diagnostic Test: FDG radiotracer